- Previous Close
808.00 - Open
808.00 - Bid 806.00 x --
- Ask 810.00 x --
- Day's Range
800.00 - 819.00 - 52 Week Range
735.00 - 953.00 - Volume
16,800 - Avg. Volume
29,286 - Market Cap (intraday)
11.374B - Beta (5Y Monthly) 0.38
- PE Ratio (TTM)
9.08 - EPS (TTM)
89.12 - Earnings Date Apr 14, 2025
- Forward Dividend & Yield 32.00 (3.88%)
- Ex-Dividend Date Aug 28, 2025
- 1y Target Est
--
AFC-HD AMS Life Science Co., Ltd. operates as an original equipment manufacturer of health foods and cosmetics. The company operates through five segments: Healthcare, Pharmaceutical, Department Store, Food and Beverage, and Other Business. The Healthcare segment manufactures, sells, and supplies OEM health foods, such as tablets, capsules, granules, soft drinks, and jelly; and cosmetics, including skin care and hair care products. This segment also operates as an advertising agency focused on planning and producing health information programs, and publishing health information magazines. The Pharmaceutical segment manufactures and sells Chinese herbal medicine, over-the-counter medicines, and generic medicines. The Department Store segment engages in the wholesale of watches, jewelry, and precious metal products. The Food and Beverage segment operates restaurants. The Other Business segment engages in the real estate buying, selling, management, rental, and intermediary business; construction industry; tourism, travel and hotel industry; and school lunch business. AFC-HD AMS Life Science Co., Ltd. was founded in 1969 and is headquartered in Shizuoka, Japan.
www.ams-life.com994
Full Time Employees
August 31
Fiscal Year Ends
Sector
Industry
Recent News: 2927.T
View MorePerformance Overview: 2927.T
Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2927.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2927.T
View MoreValuation Measures
Market Cap
11.36B
Enterprise Value
22.08B
Trailing P/E
9.07
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.38
Price/Book (mrq)
0.82
Enterprise Value/Revenue
0.73
Enterprise Value/EBITDA
7.13
Financial Highlights
Profitability and Income Statement
Profit Margin
4.41%
Return on Assets (ttm)
2.83%
Return on Equity (ttm)
10.09%
Revenue (ttm)
31.59B
Net Income Avi to Common (ttm)
1.39B
Diluted EPS (ttm)
89.12
Balance Sheet and Cash Flow
Total Cash (mrq)
11.43B
Total Debt/Equity (mrq)
169.00%
Levered Free Cash Flow (ttm)
--